Scribble by IKS Health

IKS Health is a care enablement services business and Scribble spans both sides of the line: Scribble Now is genuinely AI first, while Transcribe and Live are majority human labour with technology supporting them. Strip the generative layer out and a substantial virtual scribing and transcription business remains, which is the moat is not the model pattern this index applies across the human scribe cluster of Speke, ScribeRyte and iScribeHealth. Worth recording that the human workforce is also an ASSET to the AI here rather than only a legacy: the vendor states that having scribes on staff enables expert review of the AI output, improving it.

The strongest oversight architecture assessed in this category, and it earns the grade on a design property no competitor offers. Other vendors sell oversight as a tier chosen at contract; Scribble builds an escalation path INTO the workflow so a clinician can select the level of support PER ENCOUNTER based on complexity, sending a straightforward visit to full automation and a complex or high risk one up the chain without leaving the product. That matches oversight intensity to clinical risk, which is what this axis is actually asking about. The upper tiers are substantive rather than cosmetic: Scribble Swift puts a trained scribe on hallucination detection, and Scribble Pro escalates to CLINICIAN level review with medications, problem lists, orders and other clinical data reconciled explicitly to eliminate hallucinations and misinterpretation. Held short of perfection only by the absence of any published error rate or acceptance figure for the automated tier, which is the number that would tell a buyer when to escalate.

Technology is described only as automated speech recognition plus generative AI, with no accuracy figure, model card, named models or evaluation methodology located. What the vendor does specify precisely is turnaround, with distinct service levels of roughly two minutes, one to two hours and four hours by tier, which is unusual operational disclosure and lets a buyer plan around it. But turnaround measures speed, not correctness, and the accuracy claim rests on the human layers rather than on any published model performance.

Genuine third party recognition, with one precision that matters. IKS Health was named a 2026 Best in KLAS provider for VIRTUAL SCRIBE, which is buyer survey based rather than vendor asserted and is the kind of evidence this index has credited before, but the award category is virtual scribing rather than ambient AI, so it validates the services business and the organisation rather than the generative product specifically. Three 2026 Black Book awards and a named customer executive at a regional physician group add to the picture. No study, controlled evaluation or published accuracy benchmark for the AI tiers was located.

The human review layers create the same exposure this index graded down for Speke and ScribeRyte: trained staff read draft documentation containing PHI, and nothing was located about where that workforce sits or how it is vetted. One specific engineered control deserves credit against that: in the virtual scribing tier, scribes never access video during telehealth encounters, which is a designed restriction on what a human reviewer can see rather than a policy promise. No retention schedule, de identification practice or statement on whether customer content trains models was located.

Not assessed. No product specific business associate agreement posture was located in this pass. For the human review tiers, a buyer should confirm the agreement covers the review workforce and not only the software.

Not assessed. No named or dated attestation and no trust centre located in this pass.

Not a regulated medical device and none claimed or required for ambient documentation.

Graded up on candour and architecture rather than on a disclosure document. IKS Health publishes an unusually honest assessment of its own product category, writing that ambient scribe adoption OUTPACED VALIDATION AND OVERSIGHT and introduced risks including hallucinations, data inaccuracies and gaps in contextual nuance. A vendor naming the failure mode of the category it sells into is rare, and the escalation architecture is the design response to it, which makes the criticism structural rather than rhetorical. Two things hold it at B. No fairness statement, subgroup analysis or accent and dialect performance disclosure was located. And the E&M coding in the top tier is framed partly as reducing the risk of UNDERCODING, which is a revenue direction, though it sits at the mild end of the gradient this index tracks and is paired with clinician reconciliation and audit ready framing.

Notes are delivered into the record rather than transferred, with direct access to Scribble inside Epic through the Connection Hub, which the vendor positions as reducing IT burden at deployment. The upper tiers go further than text: clinical information is extracted into discrete data fields and mapped to clinician selected diagnoses, and medications, labs, imaging, referrals and follow ups are queued for sign off. Structured extraction rather than narrative delivery is the meaningful distinction. Held at B because Epic is the only named integration path verified in this pass.

Not assessed. No hosting region, residency option or sub processor detail was located, and the question extends to where the human review workforce operates for the validated tiers.

No published rate card for any of the five tiers. That is a larger gap here than for a single product vendor, because the tiers differ from one another by successive layers of human labour, so the price ladder across Now, Swift and Pro would show what each level of verification costs. Enterprise sold to health systems and physician groups.

Coverage extends across the visit rather than sitting inside it: pre visit chart preparation with prior visit and external record summarisation, live documentation using the clinician's own templates and macros, visit summaries and discharge instructions ready by check out, and referral letters, clearance documents and care coordination afterwards. Telehealth is supported across platforms. Problem based charting is offered as a distinct note structure, which suits complex multi problem patients better than a standard SOAP note. No specialty count or language coverage published.